AJANTPHARMNSEAjanta Pharma Limited· PharmaceuticalsLowNeutral
Announced Mon, 28 Jul · 17:18 IST

Ajanta Pharma Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ajanta Pharma has informed the exchanges that the audio recording of its Q1 FY2026 earnings call, held on 28th July 2025 at 4:00 p.m., has been uploaded on the company's website. A link to the audio file has been shared with BSE and NSE. The company has also noted that a written transcript of the earnings call will be submitted in due course. The filing is made under SEBI's Regulation 30 disclosure requirements. This is a routine procedural filing with no financial details or guidance included in the document itself.

Likely market impact

No direct impact on stock price from this filing as it only confirms availability of the earnings call recording. Investors seeking actual Q1 performance details and management commentary will need to listen to the audio or wait for the written transcript.